278 related articles for article (PubMed ID: 26893557)
41. A Pilot Study Into the Use of FDG-mNP as an Alternative Approach in Neuroblastoma Cell Hyperthermia.
Subramanian M; Pearce G; Guldu OK; Tekin V; Miaskowski A; Aras O; Unak P
IEEE Trans Nanobioscience; 2016 Sep; 15(6):517-525. PubMed ID: 27824574
[TBL] [Abstract][Full Text] [Related]
42. Core-shell structure of Fe
Zhao XF; Wang WY; Li XD; Li SP; Song FG
Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():422-428. PubMed ID: 29752115
[TBL] [Abstract][Full Text] [Related]
43. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
[TBL] [Abstract][Full Text] [Related]
44. Methotrexate loaded self stabilized calcium phosphate nanoparticles: a novel inorganic carrier for intracellular drug delivery.
Mukesh U; Kulkarni V; Tushar R; Murthy RS
J Biomed Nanotechnol; 2009 Feb; 5(1):99-105. PubMed ID: 20055112
[TBL] [Abstract][Full Text] [Related]
45. PEG capped methotrexate silver nanoparticles for efficient anticancer activity and biocompatibility.
Muhammad Z; Raza A; Ghafoor S; Naeem A; Naz SS; Riaz S; Ahmed W; Rana NF
Eur J Pharm Sci; 2016 Aug; 91():251-5. PubMed ID: 27132812
[TBL] [Abstract][Full Text] [Related]
46. Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate.
Salehi R; Rasouli S; Hamishehkar H
Int J Pharm; 2015 Jun; 487(1-2):274-84. PubMed ID: 25895723
[TBL] [Abstract][Full Text] [Related]
47. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery.
Kaasgaard T; Andresen TL; Jensen SS; Holte RO; Jensen LT; Jørgensen K
Chem Phys Lipids; 2009 Feb; 157(2):94-103. PubMed ID: 19094974
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and in vitro evaluation of pH-sensitive magnetic nanocomposites as methotrexate delivery system for targeted cancer therapy.
Wu J; Deng A; Jiang W; Tian R; Shen Y
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():132-140. PubMed ID: 27987687
[TBL] [Abstract][Full Text] [Related]
49. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier.
Han JH; Oh YK; Kim DS; Kim CK
Int J Pharm; 1999 Oct; 188(1):39-47. PubMed ID: 10528081
[TBL] [Abstract][Full Text] [Related]
50. Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance.
Ren Y; Zhang H; Chen B; Cheng J; Cai X; Liu R; Xia G; Wu W; Wang S; Ding J; Gao C; Wang J; Bao W; Wang L; Tian L; Song H; Wang X
Int J Nanomedicine; 2012; 7():2261-9. PubMed ID: 22619560
[TBL] [Abstract][Full Text] [Related]
51. Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment.
Petryk AA; Giustini AJ; Gottesman RE; Kaufman PA; Hoopes PJ
Int J Hyperthermia; 2013 Dec; 29(8):845-51. PubMed ID: 24144336
[TBL] [Abstract][Full Text] [Related]
52. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
53. Inorganic nanovehicle targets tumor in an orthotopic breast cancer model.
Choi G; Kwon OJ; Oh Y; Yun CO; Choy JH
Sci Rep; 2014 Mar; 4():4430. PubMed ID: 24651154
[TBL] [Abstract][Full Text] [Related]
54. Silibinin improves the cytotoxicity of methotrexate in chemo resistant human rhabdomyosarcoma cell lines.
Hussain SA; Marouf BH
Saudi Med J; 2013 Nov; 34(11):1145-50. PubMed ID: 24252892
[TBL] [Abstract][Full Text] [Related]
55. Lipid and TPGS based novel core-shell type nanocapsular sustained release system of methotrexate for intravenous application.
Katiyar SS; Kushwah V; Dora CP; Jain S
Colloids Surf B Biointerfaces; 2019 Feb; 174():501-510. PubMed ID: 30497012
[TBL] [Abstract][Full Text] [Related]
56. Mild magnetic nanoparticle hyperthermia enhances the susceptibility of
Alumutairi L; Yu B; Filka M; Nayfach J; Kim MH
Int J Hyperthermia; 2020; 37(1):66-75. PubMed ID: 31964196
[No Abstract] [Full Text] [Related]
57. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
Abdelbary G; Haider M
Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
[TBL] [Abstract][Full Text] [Related]
58. A novel dual-responsive core-crosslinked magnetic-gold nanogel for triggered drug release.
Ghorbani M; Hamishehkar H; Arsalani N; Entezami AA
Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():436-444. PubMed ID: 27524039
[TBL] [Abstract][Full Text] [Related]
59. A multifunctional nanomedicine platform for co-delivery of methotrexate and mild hyperthermia towards breast cancer therapy.
Ong YS; Bañobre-López M; Costa Lima SA; Reis S
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111255. PubMed ID: 32806240
[TBL] [Abstract][Full Text] [Related]
60. [Magnetically based enhancement of nanoparticle uptake in tumor cells: combination of magnetically induced cell labeling and magnetic heating].
Kettering M; Winter J; Zeisberger M; Alexiou C; Bremer-Streck S; Bergemann C; Kaiser WA; Hilger I
Rofo; 2006 Dec; 178(12):1255-60. PubMed ID: 17136650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
